Progyny Unveils Nationwide Access to Menopause Care

Integrative approach with leading providers Gennev and Midi Health to advance equitable and accessible workplace support for individuals experiencing menopause symptoms

NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced the strategic expansion of its extensive managed reproductive health network to include specialized providers of menopause care. Progyny’s employer clients who elect to include this service of tailored perimenopause and menopause care will now be able to provide timely intervention for their workforce at critical stages of health transition.

Progyny has partnered with leading providers of specialized care in the space, Gennev and Midi Health, to provide this groundbreaking access to a qualified network for specialty menopause care in all 50 states. Gennev and Midi Health offer evidence-based clinical programs and interdisciplinary care that employees can conveniently and quickly access.

“Menopause symptoms have gone widely untreated and unrecognized, impacting the retention and well-being of women during critical stages of growth in their careers,” said Dr. Janet Choi, Chief Medical Officer at Progyny. “We’re delighted to collaborate with Gennev and Midi Health to expand access to comprehensive menopause support and further demonstrate our commitment to equitable care that fills essential gaps across the reproductive health spectrum.”

Today, quality menopause care is hard to find, with fewer than one in five OB-GYNs receiving formal training in menopause medicine, according to a Johns Hopkins-led study. Individuals and families navigating perimenopause and menopause symptoms lack access to sufficient care and trusted information, causing many to shoulder sometimes debilitating symptoms – ranging from sleep disturbances and hot flashes to mental health struggles and risk factors for chronic conditions – without support. A 2021 Mayo Clinic study estimates the impact on lost productivity and direct medical costs to be $26.6 billion annually in the U.S. alone. By integrating menopause support into Progyny’s comprehensive reproductive health offerings, employees will be better able to proactively manage the impacts to their health and well-being through streamlined access to effective care.